참고문헌
- Davis, D. L., Hoel, D., Fox, J. and Lopez, A. : International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 336, 474 (1990). https://doi.org/10.1016/0140-6736(90)92020-I
- Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thun, M. J. : Cancer statistics, 2008. CA Cancer. J. Clin. 58, 71 (2008).
- Bar-Sela, G. and Haim, N. : Abnoba-viscum (mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy. Med. Oncol. 21, 251 (2004). https://doi.org/10.1385/MO:21:3:251
- de Gramont, A., Tournigand, C., Louvet, C., Maindrault-Goebel, F. and Andre, T. : First-line therapy for advanced colorectal cancer. Curr. Oncol. Rep. 7, 167 (2005). https://doi.org/10.1007/s11912-005-0069-y
- Joosten, J., Jager, G., Oyen, W., Wobbes, T. and Ruers, T. : Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. Eur. J. Surg. Oncol. 31, 1152 (2005). https://doi.org/10.1016/j.ejso.2005.07.010
- Gravalos, C., García-Sanchez, L., Hernandez, M., Holgado, E., Alvarez, N., García-Escobar, I., Martínez, J. and Robles, L. : Surgical resection of a solitary pancreatic metastasis from colorectal cancer: a new step to a cure? Clin. Colorectal. Cancer. 7, 398 (2008). https://doi.org/10.3816/CCC.2008.n.053
- Renouf, D., Kennecke, H. and Gill, S. : Trends in chemotherapy utilization for colorectal cancer. Clin. Colorectal. Cancer. 7, 386 (2008). https://doi.org/10.3816/CCC.2008.n.051
- Kiessling, R., Klein, E. and Wigzell, H. : "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5, 112 (1975). https://doi.org/10.1002/eji.1830050208
- Lanier, L. L. : NK cell recognition. Annu. Rev. Immunol. 23, 225 (2005). https://doi.org/10.1146/annurev.immunol.23.021704.115526
- Bryceson, Y. T., March, M. E., Ljunggren, H. G. and Long, E. O. : Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214, 73 (2006). https://doi.org/10.1111/j.1600-065X.2006.00457.x
- Ljunggren, H. G. and Malmberg, K. J. : Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7, 329 (2007). https://doi.org/10.1038/nri2073
- Han, S. B., Lee, C. W., Jeon, Y. J., Hong, N. D., Yoo, I. D., Yang, K. H. and Kim, H. M. : The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology 41, 157 (1999). https://doi.org/10.1016/S0162-3109(98)00063-0
- Han, S. B., Moratz, C., Huang, N. N., Kelsall, B., Cho, H., Shi, C. S., Schwartz, O. and Kehrl, J. H. : Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 22, 343 (2005). https://doi.org/10.1016/j.immuni.2005.01.017
- Greenlee, R. T., Murray, T., Bolden, S. and Wingo, P. A. : Cancer statistics, 2000. CA Cancer. J. Clin. 50, 7 (2000).
- Moore, H. C. and Haller, D. G. : Adjuvant therapy of colon cancer. Semin Oncol. 26, 545 (1999).
- Chung, K. Y. and Saltz, L. B. : Antibody-based therapies for colorectal cancer. Oncologist. 10, 701 (2005). https://doi.org/10.1634/theoncologist.10-9-701
- Kelly, H. and Goldberg, R. M. : Systemic therapy for metastatic colorectal cancer: current options, current evidence. J. Clin. Oncol. 23, 4553 (2005). https://doi.org/10.1200/JCO.2005.17.749
- Pozzo, C., Barone, C., Szanto, J., Padi, E., Peschel, C., Bukki, J., Gorbunova, V., Valvere, V., Zaluski, J., Biakhov, M., Zuber, E., Jacques, C. and Bugat, R. : Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. Ann. Oncol. 15, 1773 (2004). https://doi.org/10.1093/annonc/mdh473
- Todryk, S. M., Chong, H., Vile, R. G., Pandha, H. and Lemoine, N. R. : Can immunotherapy by gene transfer tip the balance against colorectal cancer? Gut. 43, 445 (1998). https://doi.org/10.1136/gut.43.4.445
- Yip, D., Strickland, A. H., Karapetis, C. S., Hawkins, C. A. and Harper, P. G. : Immunomodulation therapy in colorectal carcinoma. Cancer. Treat. Rev. 26, 169 (2000). https://doi.org/10.1053/ctrv.1999.0160
- Mann, B., Gratchev, A., Böhm, C., Hanski, M. L., Foss, H. D., Demel, G., Trojanek, B., Schmidt-Wolf, I., Stein, H., Riecken, E. O., Buhr, H. J. and Hanski, C. : FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas. Br. J. Cancer. 79, 1262 (1999). https://doi.org/10.1038/sj.bjc.6690202
- Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J. L., Vivier, E., Anderson, P. and Kiessling, R. : Decreased expression of the signaltransducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer. Res. 53, 5610 (1993).
- Bremers, A. J., Kuppen, P. J. and Parmiani, G. : Tumour immunotherapy: the adjuvant treatment of the 21st century? Eur. J. Surg. Oncol. 26, 418 (2000). https://doi.org/10.1053/ejso.1999.0908
- Kalinski, P., Nakamura, Y., Watchmaker, P., Giermasz, A., Muthuswamy, R. and Mailliard, R. B. : Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines. Immunol. Res. 36, 137 (2006). https://doi.org/10.1385/IR:36:1:137
- Raja, Gabaglia, C., Diaz, de Durana, Y., Graham, F. L., Gauldie, J., Sercarz, E. E. and Braciak, T. A. : Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors. Cancer Res. 67, 2290 (2007). https://doi.org/10.1158/0008-5472.CAN-06-3399
- Takashima, K., Fujiwara, H., Inada, S., Atsuji, K., Araki, Y., Kubota, T. and Yamagishi, H. : Tracking of green fluorescent protein (GFP)-labeled LAK cells in mice carrying B16 melanoma metastases. Anticancer Res. 26, 3327 (2006).
- Thorne, S. H., Negrin, R. S. and Contag, C. H. : Synergistic antitumor effects of immune cell-viral biotherapy. Science 311, 1780 (2006). https://doi.org/10.1126/science.1121411
- Wang, W., Epler, J., Salazar, L. G. and Riddell, S. R. : Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1. Cancer. Res. 66, 6826 (2006). https://doi.org/10.1158/0008-5472.CAN-05-3529
- Kim, H. M., Kang, J. S., Lim, J., Park, S. K., Lee, K., Yoon, Y. D., Lee, C. W., Lee, K. H., Han, G., Yang, K. H., Kim, Y. J., Kim, Y. and Han, S. B. : Inhibition of human ovarian tumor growth by cytokine-induced killer cells. Arch. Pharm. Res. 30, 1464 (2007). https://doi.org/10.1007/BF02977372
- Grabert, R. C., Cousens, L. P., Smith, J. A., Olson, S., Gall, J., Young, W. B., Davol, P. A. and Lum, L. G. : Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation. Clin. Cancer. Res. 12, 569 (2006). https://doi.org/10.1158/1078-0432.CCR-05-2005
- Burns, L. J., Weisdorf, D. J., DeFor, T. E., Vesole, D. H., Repka, T. L., Blazar, B. R., Burger, S. R., Panoskaltsis-Mortari, A., Keever-Taylor, C. A., Zhang, M. J. and Miller, J. S. : IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Bone. Marrow. Transplant. 32, 177 (2003). https://doi.org/10.1038/sj.bmt.1704086
- Imai, K., Matsuyama, S., Miyake, S., Suga, K. and Nakachi, K. : Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet. 356, 1795 (2000). https://doi.org/10.1016/S0140-6736(00)03231-1
- Bobek, V., Boubelik, M., Fiserova, A., L'uptovcova, M., Vannucci, L., Kacprzak, G., Kolodzej, J., Majewski, A. M. and Hoffman, R. M. : Anticoagulant drugs increase natural killer cell activity in lung cancer. Lung. Cancer. 47, 215 (2005). https://doi.org/10.1016/j.lungcan.2004.06.012
- Whiteside, T. L. and Herberman, R. B. : Role of human natural killer cells in health and disease. Clin. Diagn. Lab. Immunol. 1, 125 (1994).
- Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S. and Aikou, T. : Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 88, 577 (2000). https://doi.org/10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V
- Takanami, I., Takeuchi, K. and Giga, M. : The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J. Thorac. Cardiovasc. Surg. 121, 1058 (2001). https://doi.org/10.1067/mtc.2001.113026
- Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A. and Moreno, M. : The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 79, 2320 (1997). https://doi.org/10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P
- Dewan, M. Z., Terunuma, H., Toi, M., Tanaka, Y., Katano, H., Deng, X., Abe, H., Nakasone, T., Mori, N., Sata, T. and Yamamoto, N. : Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells. Cancer. Sci. 97, 1381 (2006). https://doi.org/10.1111/j.1349-7006.2006.00319.x
- Dewan, M. Z., Terunuma, H., Takada, M., Tanaka, Y., Abe, H., Sata, T., Toi, M. and Yamamoto, N. : Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo. Breast Cancer. Res. Treat. 104, 267 (2007). https://doi.org/10.1007/s10549-006-9416-4
- Escudier, B., Farace, F., Angevin, E., Charpentier, F., Nitenberg, G., Triebel, F. and Hercend, T. : Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2. Eur. J. Cancer. 30A, 1078 (1994).
- Ishikawa, E., Tsuboi, K., Saijo, K., Harada, H., Takano, S., Nose, T. and Ohno, T. : Autologous natural killer cell therapy for human recurrent malignant glioma. Anticancer. Res. 24, 1861 (2004).
- Carlens, S., Gilljam, M., Chambers, B. J., Aschan, J., Guven, H., Ljunggren, H. G., Christensson, B. and Dilber, M. S. : A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells. Hum. Immunol. 62, 1092 (2001). https://doi.org/10.1016/S0198-8859(01)00313-5
- Klingemann, H. G. : Natural killer cell-based immunotherapeutic strategies. Cytotherapy 7, 16 (2005). https://doi.org/10.1080/14653240510018000
- Alici, E., Sutlu, T., Björkstrand, B., Gilljam, M., Stellan, B., Nahi, H., Quezada, H. C., Gahrton, G., Ljunggren, H. G. and Dilber, M.S. Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components. Blood. 111, 3155 (2008). https://doi.org/10.1182/blood-2007-09-110312
- Guven, H., Gilljam, M., Chambers, B. J., Ljunggren, H. G., Christensson, B., Kimby, E. and Dilber, M.S. : Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy. Leukemia. 17, 1973 (2003). https://doi.org/10.1038/sj.leu.2403083
- Alici, E., Konstantinidis, K. V., Sutlu, T., Aints, A., Gahrton, G., Ljunggren, H. G. and Dilber, M. S. : Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model. Exp. Hematol. 35, 1839 (2007). https://doi.org/10.1016/j.exphem.2007.08.006
- Basse, P. H., Whiteside, T. L. and Herberman, R. B. : Cancer immunotherapy with interleukin-2-activated natural killer cells. Mol. Biotechnol. 21, 161 (2002). https://doi.org/10.1385/MB:21:2:161
- Siegler, U., Kalberer, C. P., Nowbakht, P., Sendelov, S., Meyer-Monard, S. and Wodnar-Filipowicz, A. : Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice. Leukemia. 19, 2215 (2005). https://doi.org/10.1038/sj.leu.2403985
- deMagalhaes-Silverman, M., Donnenberg, A., Lembersky, B., Elder, E., Lister, J., Rybka,W., Whiteside, T. and Ball, E. : Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer. J. Immunother. 23, 154 (2000). https://doi.org/10.1097/00002371-200001000-00018
- Terunuma, H., Deng, X., Dewan, Z., Fujimoto, S. and Yamamoto, N. : Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections. Int. Rev. Immunol. 27, 93 (2008). https://doi.org/10.1080/08830180801911743